Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer

Clinical trial NCT02448420 · COMPLETED

Trial details

NCT number: NCT02448420
Sponsor: SOLTI Breast Cancer Research Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2015-07-01
Primary completion: 2023-09-29
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.